Supplemental Guarantor Financial Information (Consolidated Statements Of Cash Flows) (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Nov. 01, 2014	Nov. 02, 2013
Net Cash Provided by (Used for) Operating Activities	$ 370	$ (31)
Investing Activities:
Capital Expenditures	(585)	(598)
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital	0	46
Other Investing Activities	15	3
Net Cash Provided by (Used for) Investing Activities	(570)	(549)
Financing Activities:
Proceeds from Issuance of Long-term Debt	0	495
Borrowings from Revolving Facility	5	290
Repayments on Revolving Facility	(5)	(290)
Repurchase of Common Stock	(48)	(55)
Dividends Paid	(591)	(261)
Excess Tax Benefits from Share-based Compensation	41	31
Net Financing Activities and Advances to/from Consolidated Affiliates	0	0
Proceeds from Exercise of Stock Options and Other	28	22
Payments of Financing Costs	(5)	0
Net Cash Provided by (Used for) Financing Activities	(575)	232
Effects of Exchange Rate Changes on Cash and Cash Equivalents	1	0
Net Increase (Decrease) in Cash and Cash Equivalents	(774)	(348)
Cash and Cash Equivalents, Beginning of Period	1,519	773
Cash and Cash Equivalents, End of Period	745	425
L Brands, Inc.
Net Cash Provided by (Used for) Operating Activities	(260)	(253)
Investing Activities:
Capital Expenditures	0	0
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital		0
Other Investing Activities	0	0
Net Cash Provided by (Used for) Investing Activities	0	0
Financing Activities:
Proceeds from Issuance of Long-term Debt		495
Borrowings from Revolving Facility	0	290
Repayments on Revolving Facility	0	(290)
Repurchase of Common Stock	(48)	(55)
Dividends Paid	(591)	(261)
Excess Tax Benefits from Share-based Compensation	0	0
Net Financing Activities and Advances to/from Consolidated Affiliates	876	52
Proceeds from Exercise of Stock Options and Other	28	22
Payments of Financing Costs	(5)
Net Cash Provided by (Used for) Financing Activities	260	253
Effects of Exchange Rate Changes on Cash and Cash Equivalents	0	0
Net Increase (Decrease) in Cash and Cash Equivalents	0	0
Cash and Cash Equivalents, Beginning of Period	0	0
Cash and Cash Equivalents, End of Period	0	0
Guarantor Subsidiaries
Net Cash Provided by (Used for) Operating Activities	435	164
Investing Activities:
Capital Expenditures	(426)	(417)
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital		0
Other Investing Activities	0	0
Net Cash Provided by (Used for) Investing Activities	(426)	(417)
Financing Activities:
Proceeds from Issuance of Long-term Debt		0
Borrowings from Revolving Facility	0	0
Repayments on Revolving Facility	0	0
Repurchase of Common Stock	0	0
Dividends Paid	0	0
Excess Tax Benefits from Share-based Compensation	35	25
Net Financing Activities and Advances to/from Consolidated Affiliates	(881)	93
Proceeds from Exercise of Stock Options and Other	0	0
Financing Costs	0
Net Cash Provided by (Used for) Financing Activities	(846)	118
Effects of Exchange Rate Changes on Cash and Cash Equivalents	0	0
Net Increase (Decrease) in Cash and Cash Equivalents	(837)	(135)
Cash and Cash Equivalents, Beginning of Period	1,353	417
Cash and Cash Equivalents, End of Period	516	282
Non- guarantor Subsidiaries
Net Cash Provided by (Used for) Operating Activities	195	58
Investing Activities:
Capital Expenditures	(159)	(181)
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital		46
Other Investing Activities	15	3
Net Cash Provided by (Used for) Investing Activities	(144)	(132)
Financing Activities:
Proceeds from Issuance of Long-term Debt		0
Borrowings from Revolving Facility	5	0
Repayments on Revolving Facility	(5)	0
Repurchase of Common Stock	0	0
Dividends Paid	0	0
Excess Tax Benefits from Share-based Compensation	6	6
Net Financing Activities and Advances to/from Consolidated Affiliates	5	(145)
Proceeds from Exercise of Stock Options and Other	0	0
Financing Costs	0
Net Cash Provided by (Used for) Financing Activities	11	(139)
Effects of Exchange Rate Changes on Cash and Cash Equivalents	1	0
Net Increase (Decrease) in Cash and Cash Equivalents	63	(213)
Cash and Cash Equivalents, Beginning of Period	166	356
Cash and Cash Equivalents, End of Period	229	143
Eliminations
Net Cash Provided by (Used for) Operating Activities	0	0
Investing Activities:
Capital Expenditures	0	0
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital		0
Other Investing Activities	0	0
Net Cash Provided by (Used for) Investing Activities	0	0
Financing Activities:
Proceeds from Issuance of Long-term Debt		0
Borrowings from Revolving Facility	0	0
Repayments on Revolving Facility	0	0
Repurchase of Common Stock	0	0
Dividends Paid	0	0
Excess Tax Benefits from Share-based Compensation	0	0
Net Financing Activities and Advances to/from Consolidated Affiliates	0	0
Proceeds from Exercise of Stock Options and Other	0	0
Financing Costs	0
Net Cash Provided by (Used for) Financing Activities	0	0
Effects of Exchange Rate Changes on Cash and Cash Equivalents	0	0
Net Increase (Decrease) in Cash and Cash Equivalents	0	0
Cash and Cash Equivalents, Beginning of Period	0	0
Cash and Cash Equivalents, End of Period	$ 0	$ 0